Carotenoids and epigenetic aging: how fruit and vegetable intake links to lower GrimAge in postmenopausal women

By | June 11, 2026

Carotenoids are naturally occurring plant pigments found in colorful fruits and vegetables (e.g., beta-carotene, alpha-carotene, lutein, and lycopene). After dietary intake, carotenoids are absorbed in the small intestine, incorporated into circulating lipoproteins, and ultimately reflected in blood as objective biomarkers of fruit and vegetable consumption. Beyond nutrition, carotenoids act as bioactive compounds with antioxidant and potentially anti-inflammatory properties. This mechanistic profile makes them plausible candidates for influencing biological aging processes, including epigenetic changes measured by DNA methylation–based clocks.

Biological aging is not a single pathway but a composite of interacting systems, including oxidative stress, chronic low-grade inflammation, mitochondrial dysfunction, altered metabolic signaling, and cumulative DNA damage. Epigenetic aging provides a molecular readout of how those exposures accumulate over time. Epigenetic clocks estimate the rate of biological aging by quantifying DNA methylation patterns at specific cytosine–guanine (CpG) sites. A widely used construct is GrimAge, an epigenetic clock that incorporates methylation surrogates related to factors such as smoking history and plasma protein markers, and has been associated with all-cause mortality risk in multiple cohorts.

In postmenopausal women, vascular aging and inflammatory signaling often accelerate due to hormonal transitions, changes in body composition, and age-associated shifts in immune function. The Women’s Health Initiative includes a large, well-characterized population, enabling investigation of dietary exposures in relation to objective molecular measures. In this context, higher blood carotenoids—considered an objective marker because they reflect actual nutrient absorption and bioavailability—have been reported to correlate with lower GrimAge. Importantly, this relationship does not imply immediate causality in a single observational analysis; however, the biomarker alignment strengthens biological plausibility: diet quality influences circulating carotenoids, and carotenoids may modulate pathways that affect epigenetic drift.

Antioxidant capacity is a primary mechanism. Reactive oxygen species can alter DNA methylation through effects on redox-sensitive enzymes, including those involved in one-carbon metabolism and demethylation pathways. Carotenoids can quench singlet oxygen and help reduce lipid peroxidation, potentially lowering oxidative stress–mediated epigenetic damage. In parallel, carotenoids may influence inflammatory signaling. Chronic inflammation involves cytokine networks and transcription factors (e.g., NF-kB) that can affect epigenetic regulators and remodeling enzymes. By attenuating inflammatory tone, carotenoids may reduce the rate at which methylation landscapes become dysregulated.

Carotenoids also interact with metabolic health. They can influence lipid profiles and insulin sensitivity indirectly through their effects on oxidative stress and membrane integrity. Metabolic dysregulation is linked to epigenetic aging through altered substrate availability for methylation reactions (e.g., folate-related pathways) and through adiposity-associated inflammation, both of which can accelerate DNA methylation changes.

Another contributing factor is bioavailability and synergy. Whole foods provide carotenoids alongside fiber, polyphenols, vitamin C, and other micronutrients that support antioxidant systems and gut microbial balance. While blood carotenoids capture one component, the observed association likely reflects a broader dietary pattern where plant-rich intake improves multiple exposures simultaneously. Fiber and plant polyphenols can affect gut microbial metabolites (such as short-chain fatty acids) that modulate epigenetic enzymes. Therefore, even though carotenoids are measured, they may serve as both mediators and surrogates for comprehensive plant-based nutrition.

From a clinical perspective, the practical implication is not that a supplement will recreate the benefits of dietary patterns. Observational data involving blood biomarkers suggest that consistent intake of fruits and vegetables supporting higher carotenoid status may associate with a slower epigenetic aging trajectory in at-risk groups such as postmenopausal women. Risk-benefit considerations remain important: smoking, obesity, and micronutrient deficiencies can substantially alter oxidative stress burden and epigenetic aging; thus, dietary strategies should complement standard preventive care.

To translate these findings responsibly, clinicians and researchers should emphasize dietary quality targets aligned with evidence-based guidelines: prioritize a variety of colorful vegetables and fruits, include carotenoid-rich items (leafy greens for lutein, carrots for alpha- and beta-carotene, tomatoes for lycopene), and maintain overall cardiometabolic health. Longitudinal studies and randomized trials measuring both blood carotenoids and epigenetic clocks are needed to clarify causality, determine dose-response relationships, and address confounders such as physical activity, socioeconomic factors, and baseline inflammation.

Overall, the reported correlation between higher blood carotenoids and lower GrimAge suggests that plant-derived antioxidants and anti-inflammatory bioactivity may be linked to a slower pace of biological aging at the epigenetic level. These findings provide a mechanistic bridge between nutrition and molecular aging models and support the broader public health message that increasing fruit and vegetable intake is associated with more favorable biological markers of aging.

Source: FoundMyFitness Clips (@fmfclips)

News Source

SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.

SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.

Leave a Reply

Your email address will not be published. Required fields are marked *